Clinical Study
Perinatal Risks Associated with Early Vanishing Twin Syndrome following Transfer of Cleavage- or Blastocyst-Stage Embryos
Table 5
Low birth weight and multiple logistic regression to account for confounding variables.
| LBW | Standard error | Adjusted OR (95% CI) | P |
| Age (<35 versus ≥35 years) | 0.59 | 1.16 (0.43–3.14) | 0.77 | Duration of ovarian stimulation (<9 versus ≥9 days) | 1.25 | 1.24 (0.17–8.96) | 0.83 | Gonadotropin dose (<2000 versus ≥2000 IU) | 0.76 | 0.81 (0.13–5.04) | 0.82 | Peak E2 level (<2000 versus ≥2000 pg/Ml) | 0.30 | 0.86 (0.44–1.69) | 0.66 | Total number of oocytes (<10 versus ≥10) | 0.20 | 0.93 (0.18–4.13) | 0.77 | Blastocyst-stage ET (yes versus no) | 0.11 | 0.85 (0.66–1.99) | 0.20 |
|
|
LBW: low birth weight; E2: estradiol; ET: embryo transfer.
|